Circle Pharma
Biotechnology company developing cell permeable macrocyclic peptide therapeutics using an automated chemistry synthesis.
4
Funding Rounds
$205.5m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma***** P. Ja****** |
|
|
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma***** P. Ja****** |
|
|
|
| Da*** J. Ea** |
|
|
|
| Jo** Jo*** |
|
|
|
| Ja*** Ev********* | - | - | - |
| Th*** Sc******* |
|
|
|
| Wa**** H. Mo** |
|
|
Funding
Funding series
Funding Series Analysis
The company Circle Pharma has raised a total of $205.5m in funding over 4 rounds.
Key Insights:
- Circle Pharma September 2024 Series D Funding round: $90m
- Circle Pharma Series C round, June 2021: $66m
- Circle Pharma Series B round, March 2020: $45m
- Circle Pharma Series A round, December 2016: $4.5m
Circle Pharma September 2024 Series D Funding round
$90m
Circle Pharma Series C round, June 2021
$66m
Circle Pharma Series B round, March 2020
$45m
Circle Pharma Series A round, December 2016
$4.5m
Industries
Circle Pharma is active in the following industries:
- Technology
- Biotechnology
- Healthcare
- Pharmaceutical industry